Canadian CANNAINVESTOR Magazine Canadian Publicly Traded April / May 2019 | Page 250

or are in development, could be a more viable option for seniors, and as the Statistica survey states, 14% choose edibles, and a whopping 38% choose something else entirely from traditional forms of delivery. For example, according to the International Journal of Pharmacy and Life Sciences, the oral transmucosal route is gaining importance for systemic drug delivery because it does have significant advantages compared to the per oral route. The oral spray technology offers formulation of many pharmacological agents making it preferred mode of delivery in diseases like angina, diabetes, and cardiovascular diseases. It allows more rapid absorption into the bloodstream than is possible with oral administration to the gastrointestinal tract. Oral spray administration is non-invasive, non-technical and convenient for patients. LP’s such as HEXO have recently introduced a spray to appeal to those that may require this type of method or prefer it. Its Elixir No.1 peppermint medical cannabis oil sublingual mist is discrete and convenient, which can appeal to all cannabis users, but seems to fit into the preferences of the elderly market segment.

Not only are cannabis companies serving this demographic through product offerings, but others such

250